Company Directory / Biotechnology Research

PrivateFor profitBiotechnology ResearchVancouver, BC, Canada
Transforming chemotherapies to further benefit patients by enhancing efficacy and improving tolerability.
Sitka Biopharma, a spin-off company of CDRD Ventures Inc., has developed a novel polymer platform technology that improves drug absorption for cancer treatments. Its lead candidate is a formulation that allows taxane drugs to adhere and penetrate into the bladder wall, enhancing treatment benefit for bladder cancer. Preclinical proof-of-concept has been established and the company’s near term goal is to gain regulatory approval to commence clinical trials.
Size
1-10 people: larger than 0% of companies with a size listed
Age
13 years old.
Reach
No web traffic ranking listed. 357 followers on LinkedIn.
BiopharmaBiotechnologyPharmaceuticalbladder cancercancerpolymerbiopharmaceuticalspharmaceuticalsbiotechnologyhyperbranched polyglycerols (HPG)drug delivery
Funding, as listed
$5.5M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Sitka Biopharma, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Biotechnology Research in Canada.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.